Top Markets
#1 Islamic Coin Islamic Coin +115.93%
#2 TEH EPIK DUCK TEH EPIK DUCK +46.31%
#3 DeXe DeXe +23.86%
#4 Akedo Akedo +16.30%
#5 TENDIES TENDIES +16.10%
#6 Manadia Manadia +14.60%
#7 Pharos Pharos +12.82%
#8 Taiko Taiko +12.68%
#9 Orochi Network Orochi Network +12.47%
#10 KGeN KGeN +9.97%
Coin of the day
Islamic Coin Islamic Coin
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Stryker Corporation Stryker Corporation

Stryker Corporation

SYK
Kedudukan dalam Saham #160
Stryker Corporation operates as a medical technology company. The company... Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Harga Saham
$336.84
Modal Pasaran
$129.13B
Perubahan (1 hari)
2.00%
Perubahan (1 tahun)
-15.94%
Negara
US
Perdagangan Stryker Corporation (SYK)

Kategori

Healthcare
Nisbah P/E bagi Stryker Corporation (SYK)
Nisbah P/E pada July 2026 TTM: 35.63
Menurut laporan kewangan dan harga saham terkini Stryker Corporation, nisbah P/E semasa (TTM) ialah 35.63. Pada akhir 2024, syarikat mempunyai nisbah P/E sebanyak 45.83.
Sejarah nisbah P/E bagi Stryker Corporation dari 2000 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
2026 (TTM) 35.63 -13.89%
2025 41.38 -9.71%
2024 45.83 27.61%
2023 35.92 -8.41%
2022 39.21 -22.44%
2021 50.56 -12.14%
2020 57.54 52.66%
2019 37.69 128.39%
2018 16.50 -70.93%
2017 56.77 108.63%
2016 27.21 11.88%
2015 24.32 -64.92%
2014 69.33 145.16%
2013 28.28 75.92%
2012 16.07 12.53%
2011 14.28 -14.55%
2010 16.72 -7.52%
2009 18.08 27.26%
2008 14.20 -52.79%
2007 30.09 4.28%
2006 28.85 8.62%
2005 26.56 -36.09%
2004 41.57 6.61%
2003 38.99 -3.57%
2002 40.43 -4.42%
2001 42.30 -5.53%
2000 44.78 0.00%
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 24.71 -30.65%
US
Medtronic plc Medtronic plc
Medtronic plc
2M6.DE
 21.15 -40.65%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 17.76 -50.15%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 47.67 33.77%
US
DexCom, Inc. DexCom, Inc.
DexCom, Inc.
DXCM.US
 30.88 -13.33%
US
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.